Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age-associated B cells, key players in autoimmune pathogenesis.

Immunity & ageing : I & A·2026
Same author

Induction of Lupus T Cell Subset by Probiotics-Matured Tolerogenic Dendritic Cells.

Food science & nutrition·2025
Same author

Immunomodulatory Effects of Multi-Strain Probiotic Capsules for Psoriatic Arthritis: A Pilot Double-Blind Randomized Controlled Trial.

Food science & nutrition·2025
Same author

Tolerogenic probiotics and gut-brain axis: targeting pain receptors in neuroimmune disorders.

Nutritional neuroscience·2025
Same author

Nanoparticle technologies in precision oncology and personalized vaccine development: Challenges and advances.

International journal of pharmaceutics: X·2025
Same author

The M2 Macrophages Importance Role in Psoriasis.

Immunity, inflammation and disease·2025

Related Experiment Video

Updated: Jun 3, 2026

Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector
08:33

Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector

Published on: February 28, 2016

New Treatment Approach Using Peptoid-Based Vaccines in Parkinson's Disease.

Seyedeh Toktam Ekrani1,2, Tola Abdulsattar Faraj3, Chnar Husam Taha3

  • 1Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Drug Development Research
|June 1, 2026
PubMed
Summary

Peptoids, N-substituted glycine oligomers, offer a promising alternative to traditional treatments for neurodegenerative diseases like Parkinson's disease (PD). Their stability and versatility present new therapeutic avenues.

Keywords:
Parkinson diseaseautoimmunityneuroimmune diseasepeptoidsvaccine

Related Experiment Videos

Last Updated: Jun 3, 2026

Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector
08:33

Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector

Published on: February 28, 2016

Area of Science:

  • Biochemistry
  • Neuroscience
  • Drug Discovery

Background:

  • Aging populations are increasing the incidence of neurodegenerative diseases, necessitating novel therapeutic strategies.
  • Parkinson's disease (PD) presents a growing challenge due to its complex pathology and limitations of current treatments.
  • Peptoids, N-substituted glycine oligomers, are emerging as a class of peptidomimetics with unique advantages.

Purpose of the Study:

  • To review the diverse applications of peptoids in the context of neurodegenerative diseases, particularly Parkinson's disease.
  • To explore the potential of peptoids as therapeutic agents and in vaccination strategies for PD.
  • To highlight the advantages of peptoids over traditional peptide-based approaches.

Main Methods:

  • This review synthesizes current research on peptoid applications in neuroprotection.
  • It examines peptoids' resistance to degradation and engineered stability for therapeutic use.
  • The review analyzes peptoids' roles in preventing protein aggregation and modulating cell signaling.

Main Results:

  • Peptoids demonstrate resistance to proteolytic degradation, enhancing their therapeutic potential in physiological environments.
  • They can be engineered for structural stability and biomarker detection, crucial for PD applications.
  • Current research indicates peptoids' efficacy in preventing protein aggregation and acting as anti-inflammatory agents.

Conclusions:

  • Peptoids offer significant advantages over peptides, including enhanced stability and versatility.
  • Their applications in preventing protein aggregation, modulating signaling pathways, and anti-inflammatory therapy show promise for PD.
  • Further development of peptoid-based strategies holds potential for improved prevention and treatment of Parkinson's disease.